REALATED ARTICLES

Click on a word or phrase in our Tag Cloud and see all related articles listed below.

 

Current tag:

Bayer AG: New Stakes in Stem Cells

Prof. Andreas Busch, Member of the Bayer HealthCare Executive Committee, responsible for Global Drug Discovery

Prof. Andreas BuschJanuary 2011. An unmasked account of decisions about investing into cancer stem cell research and the fate of regenerative medicine projects in Japan. Dr Busch summarises results and evaluates technology platforms like novel antibodies and wnt mechanisms. He voices his expectations from current key drug development partnerships, in particular with Oncomed and Micromet. Will these include companion diagnostics? To what extent does Bayer retain respective intellectual property rights? A comment on personalised medicine and cancer stem cells research pursued by Merck KGaA and others. What are prospects for classic oncology drugs?

 

 

 

Related Articles

Horizon Discovery: Mitigating risks and developing the U.S. business

Tasks ahead for Eric Rhodes, the new CTO

Roche Ethiopia: Build-up of an emerging market

Systems Biology: In search of good questions

Prof Walter Kolch on the approach taken by Systems Biology Ireland


B2Bioworld Stem Cell Insights Collection 2010:

Issues and Evaluation from Pharma Leaders

 

Dr Patrick Vallance, GSK:

Stem Cell Research Now and in the Future

 

No Mercy with Violators of Corporate Compliance

Dr Rüdiger Scheitza, Member of the Board Bayer CropScience, and Labour Director

 



If you would like to read more, please proceed to the download section.

Important: After pressing "Buy this article (PayPal)" below you will be taken to the PaypPal checkout page. There you must press the orange "Return To BioBusinessMedia" button in order to download your article.
In buying this article you agree with our Terms & Conditions which you can consult here.

3 pages, exclusive

Reprocell: Cardiomyocyte Maintenance Medium

cardiomyocytes medium (C) Reprocell 2009November 2009. Part of the QTempo series of qualified products for cardiomyocyte research. ReproCELL's cardiomyocyte maintanance medium  has been optimized and qualified for the maintanance of  cardiomyocytes. Cardiomyocytes maintained in ReproCELL's cardiomyocyte buffer can maintain spontaneous beat for wextended periods of time up to several months.
* Qualified for use with beating primate cardiomyocytes used in the QTempo system
 Cardiomyocyte maintenance Medium (100ml)    £40.00 (1 unit)

-->

Disclaimer: You agree that B2Bioworld is not responsible and will not be held liable for any third party content on its sites or any third-party content, products or services available on other web sites accessed through links from B2Bioworld sites. Links to third-party sites are for your convenience only, and their inclusion on B2Bioworld's sites does not imply any endorsement, guarantee, warranty or representation by B2Bioworld.

Drug Testing with Embryonic Stem Cells

– Towards Standards For Assays

(C) David C Hay 2009As stem cell derived models of human liver biology move closer to diagnostic implementation there is an imperative for model standardization. Fresh experimental data is provided.

 

 

 

 

 

Reference
Hay DC (2009): Drug Testing with Embryonic Stem Cells – Towards Standards For Assays. published online September 12, B2Bioworld.com.



If you would like to read more, please proceed to the download section.

Important: After pressing "Buy this article (PayPal)" below you will be taken to the PaypPal checkout page. There you must press the orange "Return To BioBusinessMedia" button in order to download your article.
In buying this article you agree with our Terms & Conditions which you can consult here.

Methods, reviewed, 3 pages

Stem Cells: a discovery tool and a potential therapeutic modality

Dr Jonathan KnowlesSeptember 2009. What are the needs for stem cell technologies in the pharmaceutical industry? What are the major challenges, and how can you ensure a close fit with external collaborators, like I-STEM? An interview with Dr Jonathan Knowles, Member of the Roche Executive Committee and Head of Group Research.

 

 

 

Related Articles

Roche Ethiopia: Build-up of an emerging market

Bayer AG: New Stakes in Stem Cells

Prof. Andreas Busch, Member of the Bayer HealthCare Executive Committee, responsible for Global Drug Discovery

 


 



If you would like to read more, please proceed to the download section.

Important: After pressing "Buy this article (PayPal)" below you will be taken to the PaypPal checkout page. There you must press the orange "Return To BioBusinessMedia" button in order to download your article.
In buying this article you agree with our Terms & Conditions which you can consult here.

exclusive interview, 2 pages

Pfizer Regenerative Medicine: “It really started last year…”

Ruth McKernan (c) Pfizer Inc.Pfizer is rapidly expanding work on stem cell applications. A first hand account by Dr Ruth McKernan, the global CSO of Pfizer’s activities in the field, an evaluation of toxicity screening with embryonic stem cells and needs to move forward.

 

 

 

 

 



If you would like to read more, please proceed to the download section.

Important: After pressing "Buy this article (PayPal)" below you will be taken to the PaypPal checkout page. There you must press the orange "Return To BioBusinessMedia" button in order to download your article.
In buying this article you agree with our Terms & Conditions which you can consult here.

exclusive interview, 3 pages

L'Oréal Makes Progress in Stem Cell Research

15-07-2009. L'Oréal's R&D strategy. Using stem cells to combat skin ageing is not without a few problems even after several years of applied research. A report in French with English summary.

L’Oréal a annoncé sa stratégie de recherche dans le domaine du vieillissement et des cellules souches lors d’une conférence au centre Charles Zviak à Clichy.

 



If you would like to read more, please proceed to the download section.

Important: After pressing "Buy this article (PayPal)" below you will be taken to the PaypPal checkout page. There you must press the orange "Return To BioBusinessMedia" button in order to download your article.
In buying this article you agree with our Terms & Conditions which you can consult here.

report in fr/summary en,1 page

Top 10 Tags

All Tags (2074)